Inhalopédia | Inhalers

Class
- Long-acting muscarinic antagonist (LAMA)
Active ingredient
- Tiotropium (as bromide)
Device
- Handihaler®
Inhalers techniques and maintenance
Age
- 18 +
Typical use
- Asthma (off-label)
  in addition to a high dose ICS + LABA when uncontrolled
Asthma management principles
- COPD
  initial treatment or in addition to a LABA when uncontrolled
COPD management principles
Marketed strength
- 18 mcg
Number of doses
- 30 capsules
Dose indicator
- Yes | Number of capsules
Usual adult dosage
- 1 inh QD
Usual pediatric dosage
- -
Required inspiratory flow
- > 20 - 30 L/min
  High internal resistance (R5)
Inspiratory flows
Public coverage
- AB – MN – NIHB – ON – QC – SK – YT | Open/Regular Benefit
  BC – NB –NL – NS – PEI | Restricted Benefit with criteria
Provincial coverage criteria
Advantages
- -
Disadvantages
- Capsule handling required
- Opaque capsule preventing confirmation of full inhalation
- High internal resistance (more effort required for inhalation)
- Capsule may be ingested
Side effects

Product monograph

Download

Spiriva®